Amelia Wong is a RECATOOLS editorial persona focused on consumer technology, digital wellness, health-related tools, calculators, and practical lifestyle explainers. Articles under this byline help readers understand everyday data, online tools, and wellness-related information without replacing professional advice.

About this byline

Amelia Wong is a RECATOOLS editorial persona for consumer technology and wellness-related tool coverage. Articles are produced and reviewed under RECATOOLS editorial supervision.

8
Articles
Health & Wellness
Primary beat
Jun 2026
Writing since
~33 min
Total reading
All 8 Health & Wellness 7 AI & ML 1

Articles · Health & Wellness Showing 1–7 of 7

Researcher reviewing health data on a screen in a lab, illustrating AI-assisted clinical-trial monitoring.
Health & Wellness

The FDA wants clinical trials to report in real time, with AI doing the watching

The US Food and Drug Administration has started two pilot trials that send their results to the agency as the data comes in, rather than in one big package at the end. The idea is to use AI and the cloud to shave months off a process that usually drags on for years. Done right, that means treatments reaching patients sooner.

1 Jun 2026 · 2 min read
Medical monitor displaying AI-generated patient risk scores in a hospital ICU ward, with nurses reviewing alert notifications on screen
Health & Wellness

Bayesian Health Wins First FDA Clearance for Continuous AI Sepsis Monitor, Study Shows 18% Mortality Drop

Bayesian Health's TREWS system became the first AI device cleared by the FDA to continuously monitor all hospitalised patients for sepsis — no prior clinical suspicion required. A 2022 Nature Medicine study anchoring the submission found an 18% reduction in in-hospital sepsis mortality when clinicians acted on alerts within three hours.

1 Jun 2026 · 5 min read
Commure AI healthcare platform dashboard showing autonomous revenue cycle management agents processing hospital billing workflows
Health & Wellness

Commure Raises US$70M at US$7B Valuation to Deploy AI Agents Across Hospital Administration

On 19 May 2026, Commure closed a US$70 million round at a US$7 billion post-money valuation, led by General Catalyst. Its AI agents already complete more than 85% of revenue cycle work without human involvement across 500+ healthcare organisations — and the company is now pointed at international markets.

1 Jun 2026 · 5 min read
A child using an inhaled insulin device, representing the FDA approval of Afrezza for paediatric diabetes treatment in May 2026
Health & Wellness

FDA Approves First Inhaled Insulin for Children: Afrezza Clears Paediatric Label After a Century of Injections

On 29 May 2026, the FDA cleared Afrezza inhaled insulin for children and adolescents aged 6 and older — the first inhaled mealtime insulin approved for paediatric use anywhere. The Phase 3 INHALE-1 trial showed no meaningful lung-function decline, though its primary HbA1c endpoint requires context: the full intent-to-treat analysis narrowly missed non-inferiority.

1 Jun 2026 · 6 min read
NVision Quantum Technologies POLARIS MRI system in a clinical research setting, Ulm Germany
Health & Wellness

German Quantum Health Startup NVision Raises US$55M to Combine Quantum MRI and Drug Discovery in One Pipeline

Abbott led a US$55 million Series B into NVision Quantum Technologies, a German startup using quantum physics to run cancer imaging and drug development on a single integrated platform. Total funding now stands at US$120 million.

1 Jun 2026 · 5 min read
A pathologist examines a digitised breast tissue slide on a screen, representing AI-assisted cancer risk stratification
Health & Wellness

FDA Clears ArteraAI Breast: The First AI Digital Pathology Tool to Guide Breast Cancer Chemotherapy Decisions

On 6 May 2026, Artera's ArteraAI Breast became the first FDA-cleared digital pathology AI tool to stratify early-stage breast cancer patients by chemotherapy need — working from a biopsy slide already in the lab, with same-day results, and backed by data from over 8,500 patients.

1 Jun 2026 · 5 min read
Close-up of a fitness tracker worn on a wrist, illustrating the health-tracking wearable category.
Health & Wellness

The Oura Ring 5 is here, smaller and screenless, as smart rings have a moment

Oura has launched its fifth-generation smart ring: 40 per cent smaller than the last one, US$399, and shipping from 4 June. It arrives just as rivals stumble, with Samsung's Galaxy Ring 2 stuck in a patent dispute. The screenless wearable is having its moment.

1 Jun 2026 · 2 min read
Editorial Policy →